Innovative Modifications to the LASSI‐L Cognitive Challenge Test

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Alzheimer's & Dementia vol. 21 (Dec 1, 2025)
1. Verfasser: Ortega, Alexandra
Veröffentlicht:
John Wiley & Sons, Inc.
Schlagworte:
Online-Zugang:Citation/Abstract
Full Text - PDF
Tags: Tag hinzufügen
Keine Tags, Fügen Sie das erste Tag hinzu!

MARC

LEADER 00000nab a2200000uu 4500
001 3286441238
003 UK-CbPIL
022 |a 1552-5260 
022 |a 1552-5279 
024 7 |a 10.1002/alz70857_098431  |2 doi 
035 |a 3286441238 
045 0 |b d20251201 
100 1 |a Ortega, Alexandra  |u University of Miami Leonard M. Miller School of Medicine, Miami, FL, USA, 
245 1 |a Innovative Modifications to the LASSI‐L Cognitive Challenge Test 
260 |b John Wiley & Sons, Inc.  |c Dec 1, 2025 
513 |a Journal Article 
520 3 |a Background Early detection of Alzheimer's disease (AD) and related dementias (ADRD) is critical as this is when emerging therapies are most effective. Traditional cognitive assessments often lack sensitivity to detect subtle early deficits, and specificity required to identify ADRD. To address these limitations, our lab has developed and continuously refined the Loewenstein‐Acevedo Scales for Semantic Interference and Learning (LASSI‐L), a novel cognitive challenge test (CCT) that targets cognitive vulnerabilities associated with AD. Method Core components include the assessment of proactive semantic interference (PSI) and the failure to recover from proactive semantic interference (frPSI), aspects associated with deficits in semantic processing. The LASSI‐L employs semantic category cues during encoding and retrieval to facilitate learning, reduce reliance on individualized learning strategies and enhance recall. Early executive and inhibitory control deficits can be assessed using the Percent Intrusion Errors (PIE) metric. This metric represents the ratio of semantic intrusion errors (SIEs), which occur when individuals fail to suppress irrelevant, competing information in favor of identifying correct targets. The addition of a delayed semantic source memory recognition task was designed to evaluate deficits in source memory and enhance detection of SIEs. This CCT has been fully digitized featuring a Cloud‐based software using voice recognition technology and is available in English and Spanish. Integration with amyloid PET imaging and plasma‐based biomarkers (e.g., p‐tau181, p‐tau217), to improve diagnostic precision and validate its use in identifying AD‐specific cognitive deficits. Results Delayed semantic source memory recognition task resulted in increased identification of SIEs linked to executive function and source memory deficits. SIEs have been found to be highly discriminative between those with amnestic Mild Cognitive Impairment (aMCI) with amyloid PET positivity. SIEs also differentiate between aMCI who are plasma p‐tau181+ versus p‐tau181‐and those who are p‐tau217+ versus p‐tau217‐. Deficits have been correlated with amyloid load and hippocampal atrophy. PIE has shown high sensitivity and specificity, distinguishing preclinical AD from cognitively unimpaired individuals. Conclusion This presentation will discuss the innovative modifications to the LASSI‐L. This CCT holds promise as an accessible tool for early AD/ADRD detection, particularly in diverse and underserved populations, and complements emerging biomarker‐based approaches to diagnosis. 
653 |a Semantic memory 
653 |a Alzheimer's disease 
653 |a Voice recognition 
653 |a Spanish language 
653 |a Errors 
653 |a Memory 
653 |a Medical diagnosis 
653 |a Encoding (Cognitive process) 
653 |a Executive control 
653 |a Politics 
653 |a Retrieval 
653 |a Cognition 
653 |a Learning strategies 
653 |a Cues 
653 |a Acknowledgment 
653 |a Recall 
653 |a Semantic processing 
653 |a Cognitive impairment 
653 |a Semantic categories 
653 |a Encoding 
653 |a Executive function 
653 |a Response inhibition 
653 |a Biological markers 
653 |a Intrusion 
653 |a Innovations 
653 |a Biomarkers 
653 |a Source memory 
653 |a Underserved populations 
653 |a Semantics 
653 |a Learning transfer 
773 0 |t Alzheimer's & Dementia  |g vol. 21 (Dec 1, 2025) 
786 0 |d ProQuest  |t Consumer Health Database 
856 4 1 |3 Citation/Abstract  |u https://www.proquest.com/docview/3286441238/abstract/embedded/L8HZQI7Z43R0LA5T?source=fedsrch 
856 4 0 |3 Full Text - PDF  |u https://www.proquest.com/docview/3286441238/fulltextPDF/embedded/L8HZQI7Z43R0LA5T?source=fedsrch